Other Countries Rate Half of Top-Selling Drugs in Medicare as Low Added Benefit
These low added therapeutic-rating drugs accounted for $19.3 billion or one-third of Medicare annual net spending in 2020
Many Older Americans Would Like to Take Fewer Meds, Poll Reveals
Older Americans think they take too many medicines, and a sizable percentage said they have cut back
Anti-PD-1 More Effective With Normal Vitamin D Levels in Melanoma
Significantly higher response rate and longer progression-free survival seen for patients with normal vitamin D
Biden to Nominate Head of National Cancer Institute to Run NIH
A new leader for the U.S. National Institutes of Health could put a fresh focus on efforts to cut cancer death rates
Good Agreement Found for Clinical, Photograph Assessment of Psoriasis
Intraclass correlation coefficient 0.78 between clinical and photographic Psoriasis Area and Severity Index
Child With Psoriasis Negatively Impacts Mom’s Quality of Life
Positive association seen between mothers' Family Dermatology Life Quality Index scores and children's Psoriasis Area Severity Index scores
USPSTF: Evidence Lacking for Screening Asymptomatic Patients for Skin Cancer
Current evidence is insufficient for assessing balance of benefits and harms of screening asymptomatic adults, adolescents
Universal Masking in Health Care No Longer Seems Appropriate
Maintaining masking may offer marginal benefit in terms of reducing transmission, but impedes communication
AACR: mRNA-4157 Plus Pembrolizumab Beneficial in Melanoma
Combination of mRNA vaccine and pembrolizumab significantly prolongs recurrence-free survival versus pembrolizumab alone
Incidence of Mpox Higher for Most Racial, Ethnic-Minority Groups
Vaccination-to-case ratio was lower for Black and Hispanic versus White men during full analytic period
